Tin tức & Cập nhật
Xem bài viết Khớp
Xem
Chỉ hiển thị Multimedia

Gender, CRP, biologic use predict secukinumab effectiveness in patients with PsA
15 Sep 2026
bởiStephen Padilla
Male sex, elevated C-reactive protein (CRP), lower number of previous biologic/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARD) used, and lower Health Assessment Questionnaire (HAQ) score are all predictive of treatment response in European patients with psoriatic arthritis (PsA) treated with secukinumab, a study has shown.
15 Sep 2026







